Corrigendum to “novel pH-responsive E-selectin targeting natural polysaccharides hybrid micelles for diabetic nephropathy” [nanomedicine: nanotechnology, biology and medicine, volume 52, august 2023, 102,696]

IF 4.6 2区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2025-06-12 DOI:10.1016/j.nano.2025.102832

Ph.D Chunjing Guo , MD Min Cao , MD Ningning Diao , MD Wenxin Wang , MD Hongxu Geng , MD Yanguo Su , BD Tianying Sun , BD Xinyue Lu , Ph.D Ming Kong , Ph.D Daquan Chen

引用次数: 0

查看原文本刊更多论文

“针对糖尿病肾病的天然多糖混合胶束的新型ph反应性e -选择素”的更正[纳米医学：纳米技术，生物学和医学，第52卷，2023年8月，102,696]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nanomedicine : nanotechnology, biology, and medicine 工程技术-纳米科技

CiteScore

11.10

自引率

0.00%

发文量

133

审稿时长

42 days

期刊介绍： The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.